Navigation Links
FDA okays new GE tomography system

Waukesha, Wis. GE Healthcare has received federal approval for yet another medical device technology, and this one promises better imaging for the estimated 20% of Americans that are considered obese.

The company announced Thursday it has received clearance from the Food and Drug Administration for its new wide bore computed tomography (C......

Full article >>> GE Healthcare announced the integration of 4D imaging and planning to enable oncologists to see the precise location of tumors and critical structures in motion.

Last week, GE was granted approval for a digital mammography system that produces a better image for the detection of breast cancer.......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 05/01/06


Related biology technology :

1. Rapid hit confirmation and early hERG liability testing using the IonWorks HT system
2. High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system
3. Matched siRNAs and Assays: Ambion + Applied Biosystems = RNAi Success
4. Performance of Ad-A-Gene EGFP-Glucocorticoid Receptor (EGFP-GCCR): an adenoviral vector gene delivery system
5. Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system
6. Multiplex protein detection with the ECL Plex fluorescent Western blotting system using the Ettan DIGE Imager
7. Performance of Ad-A-Gene Cyclic AMP Response Element-Nitroreductase (CRE-NTR): an adenoviral vector gene delivery system
8. Amplified Fragment Length Polymorphism (AFLP) Analysis on Applied Biosystems Capillary Electrophoresis Systems
9. A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology
10. Kodak in vivo imaging system: precise coregistration of molecular imaging with anatomical X-ray imaging in animals
11. A technique for increasing yields in bioreactors and disposable cell-culture systems
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/24/2016)... , June 24, 2016 Epic Sciences ... detects cancers susceptible to PARP inhibitors by targeting ... cells (CTCs). The new test has already been ... in multiple cancer types. Over 230 ... damage response pathways, including PARP, ATM, ATR, DNA-PK ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... ... 23, 2016 , ... UAS LifeSciences, one of the leading ... UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing high ... its list of well-respected retailers. This list includes such fine stores as Whole ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
(Date:5/16/2016)... NEW YORK , May 16, 2016   ... authentication solutions, today announced the opening of an IoT ... to strengthen and expand the development of embedded ... provides an unprecedented level of convenience and security with ... to authenticate one,s identity aside from DNA. EyeLock,s platform ...
(Date:4/28/2016)... First quarter 2016:   , ... the first quarter of 2015 The gross margin was ... 18.8) and the operating margin was 40% (-13) Earnings ... flow from operations was SEK 249.9 M (21.2) , ... SEK 7,000-8,500 M. The operating margin for 2016 is ...
(Date:4/15/2016)... DUBLIN , April 15, 2016 ... of the,  "Global Gait Biometrics Market 2016-2020,"  report ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait ... CAGR of 13.98% during the period 2016-2020. ... movement angles, which can be used to compute ...
Breaking Biology News(10 mins):